Bollard, Catherine M; Gottschalk, Stephen; Torrano, Vicky et al. (2014) Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins. J Clin Oncol 32:798-808
|
Bollard, Catherine M; Straathof, Karin C M; Huls, M Helen et al. (2004) The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease. J Immunother 27:317-27
|
Bollard, Catherine M; Aguilar, Laura; Straathof, Karin C et al. (2004) Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease. J Exp Med 200:1623-33
|
Huls, M Helen; Rooney, Cliona M; Heslop, Helen E (2003) Adoptive T-cell therapy for Epstein-Barr virus-positive Hodgkin's disease. Acta Haematol 110:149-53
|
Gottschalk, Stephen; Edwards, Oliver L; Sili, Uluhan et al. (2003) Generating CTLs against the subdominant Epstein-Barr virus LMP1 antigen for the adoptive immunotherapy of EBV-associated malignancies. Blood 101:1905-12
|
Wagner, Hans-Joachim; Rooney, Cliona M; Heslop, Helen E (2002) Diagnosis and treatment of posttransplantation lymphoproliferative disease after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 8:1-8
|
Gottschalk, Stephen; Heslop, Helen E; Roon, Cliona M (2002) Treatment of Epstein-Barr virus-associated malignancies with specific T cells. Adv Cancer Res 84:175-201
|
Rooney, C M; Bollard, C; Huls, M H et al. (2002) Immunotherapy for Hodgkin's disease. Ann Hematol 81 Suppl 2:S39-42
|
Gahn, Benedikt; Hunt, Garrett; Rooney, Cliona M et al. (2002) Immunotherapy to reconstitute immunity to DNA viruses. Semin Hematol 39:41-7
|
Rooney, C M; Aguilar, L K; Huls, M H et al. (2001) Adoptive immunotherapy of EBV-associated malignancies with EBV-specific cytotoxic T-cell lines. Curr Top Microbiol Immunol 258:221-9
|
Showing the most recent 10 out of 13 publications